Smith & Nephew (SNN) Long-Term Investments (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Long-Term Investments of $121.0 million for Q4 2025, up 1628.57% year-on-year from $7.0 million in Q4 2024, and up 1628.57% on a QoQ basis from $7.0 million in Q2 2025.
Smith & Nephew (SNN) Long-Term Investments (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Long-Term Investments for 17 consecutive years, with $121.0 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Investments rose 1628.57% year-over-year to $121.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.0 million (up 1628.57% YoY) and the FY2025 annual result came in at $121.0 million, up 1628.57% from the prior year.
- Long-Term Investments grew to $121.0 million in Q4 2025 per SNN's latest filing, from $7.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for SNN reached as high as $188.0 million in Q4 2021 and fell as low as $7.0 million in Q4 2024.
- A 5-year average of $57.1 million and a median of $16.0 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 75.53% — and 2025, when it surged 1628.57%.
- Year by year, Long-Term Investments stood at $188.0 million in 2021, then slumped by 75.53% to $46.0 million in 2022, then slumped by 65.22% to $16.0 million in 2023, then plunged by 56.25% to $7.0 million in 2024, then jumped by 1628.57% to $121.0 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $121.0 million, $7.0 million, and $7.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 121.00 Mn |
| Jun 28, 2025 | 7.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Jun 29, 2024 | 15.00 Mn |
| Dec 31, 2023 | 16.00 Mn |
| Dec 31, 2022 | 46.00 Mn |
| Dec 31, 2021 | 188.00 Mn |
| Dec 31, 2020 | 108.00 Mn |
| Jun 30, 2020 | 10.00 Mn |
| Dec 31, 2019 | 103.00 Mn |
| Jun 29, 2019 | 9.00 Mn |
| Dec 31, 2018 | 105.00 Mn |
| Jun 30, 2018 | 21.00 Mn |
| Dec 31, 2017 | 118.00 Mn |
| Dec 31, 2016 | 112.00 Mn |
| Dec 31, 2015 | -25.00 Mn |
| Jun 30, 2015 | 13.00 Mn |
| Dec 31, 2014 | -2.00 Mn |
| Sep 30, 2014 | 2.00 Mn |
| Jun 28, 2014 | 2.00 Mn |